Skip to main content

Table 2 Mortality in patients with and without DM in different patients subgroups

From: Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

  Factor present
  Yes No
  DM Non-DM P value DM Non-DM P value
Age > 80 (%) 7.5 3.8 0.071 1.5 0.3 0.006
Female gender (%) 5.0 1.2 0.001 2.0 0.9 0.098
Hypertension (%) 3.3 1.1 0.003 0.0 0.7 0.362
Hypercholesterolemia (%) 3.3 1.2 0.012 1.5 0.7 0.378
Smoking (%) 1.0 0.2 0.262 3.4 1.2 0.004
Chronic renal failure (%) 9.9 2.8 0.036 2.0 0.9 0.044
Peripheral artery disease (%) 3.1 3.1 1.000 3.0 0.8  < 0.001
Previous CAD (%) 2.4 1.8 0.537 3.0 0.7 0.001
Previous infarction (%) 2.4 0.6 0.314 3.1 1.1 0.002
Previous PCI (%) 2.4 0.4 0.165 3.2 1.1 0.003
Previous CABG (%) 0.0 6.3 0.242 3.2 0.9  < 0.001
Previous valve replacement (%) 4.3 1.5 0.444 2.6 0.8 0.002
Left ventricular dysfunction (%) 1.6 0.7 0.370 3.2 1.0 0.001
NYHA > 2 (%) 7.1 2.5 0.061 2.1 0.7 0.014
CCS > 2 (%) 4.8 3.9 1.000 2.7 0.7 0.001
  1. PC Percutaneous coronary intervention. CABG Coronary artery bypass grafting, NYHA New York Heart Association, CCS Cardiology Canadian Society